Self-Management for People with Inflammatory Bowel Disease by Fred Saibil, Emily Lai, Andrew Hayward, Jeanne Yip, Cameron Gilbert

“…The present paper reviews some of the literature on self-management for the patient with inflammatory bowel disease (IBD), and provides a framework for the use of self-management in the IBD population, with emphasis on the concept of a patient passport, and the use of e-mail, supported by an e-mail contract, as proposed by the Canadian Medical Protective Association. …”
Get full text

The Economic Burden of Irritable Bowel Syndrome in Canada by Judith D Bentkover, Christopher Field, Evelyn M Greene, Victor Plourde, Julian P Casciano

“…In the treatment of irritable bowel syndrome (IBS), medical practitioners and policymakers face the task of providing both high quality and cost effective medical care for a condition with no certain cure. …”
Get full text

Management of Multiple Arteriovenous Malformations of the Small Bowel by Masahiro Hirakawa, Rie Ishizuka, Masanori Sato, Naotaka Hayasaka, Hiroyuki Ohnuma, Kazuyuki Murase, Kohichi Takada, Tatsuya Ito, Takayuki Nobuoka, Koji Miyanishi, Masayoshi Kobune, Ichiro Takemasa, Junji Kato

“…A 62-year-old Japanese female was referred to our hospital with gastrointestinal bleeding. Although small-bowel bleeding was suspected, no bleeding source was identified by enhanced computed tomography (CT), video capsule endoscopy (VCE), and double-balloon enteroscopy (DBE). …”
Get full text

Noninvasive markers of inflammatory bowel disease activity by A. V. Nikitin, L. V. Vasilyeva, Anatoly A. Matiukhin

“…To study noninvasive activity markers of inflammatory bowel diseases (IBD) and to estimate correlation between various diagnostic methods for an assessment of clinical and endoscopical activity of ulcerative colitis (UC) and Crohn's disease (CD). …”
Get full text

Delayed Intraperitoneal Catheter Erosion into the Small Bowel by Lauren Kerwin, Sean Calhoun

“…One of these delayed complications is catheter erosion into adjacent bowel.…”
Get full text

Role of Opioid Ligands in the Irritable Bowel Syndrome by Enrico Corazziari

“…Diphenoxylate and, more efficiently, loperamide, for the lack of any effect on the central nervous system, have been usefully employed in the treatment of diarrhea in irritable bowel syndrome (IBS) patients. Unlike the mu receptor agonists morphine and loperamide, which invariably stimulate colonic motility, trimebutine, which has almost equal affinity for mu, delta and kappa receptors, has no effect on normal colonic activity but reduces the abnormal increase in postprandial motor activity in IBS patients and accelerates slow large bowel transit in constipated patients. …”
Get full text

Capsule Endoscopy in the Small Bowel Crohn’s Disease by Federico Argüelles-Arias, Juan Rodríguez-Oballe, Calixto Duarte-Chang, Luisa Castro-Laria, Josefa María García-Montes, Ángel Caunedo-Álvarez, Juan Manuel Herrerías-Gutiérrez

“…CD is a chronic inflammatory disorder associated to mucosal and transmural inflammation of the bowel wall. It is well known that CD can affect the entire gastrointestinal. …”
Get full text

Update in Small Bowel Physiology: Part 2 by RJ Fingerote, S Churnratanakul, M Keelan, K Madsen, ABR Thomson

“…In this review a summary of the past year's literature is presented which will draw attention to the considerable progress in small bowel physiology which will soon be translated into an improved understanding of the pathophysiology of a variety of intestinal disorders.…”
Get full text

The Role of Macrophages in the Pathogenesis of Inflammatory Bowel Disease by YR Mahida

Get full text

Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases by Donatella Comito, Claudio Romano

“…Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract that occur in genetically susceptible individuals. …”
Get full text

Potential Human Models of Infammatory Bowel Disease by Stephen B Hanauer

“…Similar to animal models of inflammatory bowel disease (IBD), there is no single human model representative of ulcerative colitis or Crohn's disease. …”
Get full text

Immunologists' Perspectives on Monogenic Inflammatory Bowel Diseases by Maryiam Jama Ali Osman, Emine Selva Aydoğdu, Rafah Mackeh, Ahmet Özen, Bernice Lo

Subjects: “…inflammatory bowel diseases…”
Get full text

Immunization History of Children with Inflammatory Bowel Disease by Ing Shian Soon, Jennifer CC deBruy, Iwona Wrobel

“…BACKGROUND: Protection against vaccine-preventable diseases is important in children with inflammatory bowel disease (IBD) due to frequent immunosuppressive therapy use. …”
Get full text

Sexual functions in individuals with inflammatory bowel diseases by Marta Kotkowicz-Szczur, Edyta Szymańska, Rafał Kisielewski, Jarosław Kierkuś

Subjects: “…inflammatory bowel disease…”
Get full text

Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease by Tejas Sheth, C. S. Pitchumoni, Kiron M. Das

“…Musculoskeletal manifestations are the most common extraintestinal manifestations in inflammatory bowel diseases. Some appendicular manifestations are independent of gut inflammation and are treated with standard anti-inflammatory strategies. …”
Get full text

Irritable Bowel Syndrome in Terms of Changes in the Microbiota by Vladimir T. Ivashkin, Oxana Yu. Zolnikova

Subjects: “…irritable bowel syndrome…”
Get full text

Bowel diseases and constipation in practice of the obstetrician and gynecologist by I. V. Kuznetsova, Yu. B. Uspenskaya

Subjects: Get full text

Update of Immunomodulatory Therapy for Inflammatory Bowel Disease by Charles N Bernstein

“…For several decades corticosteroids were the only potent immunomodulatory agents effective and available for active inflammatory bowel disease (IBD). The past decade ha seen an enhanced knowledge of the immune response in lBD and a better understanding of how common immunomodulatory agents work. …”
Get full text

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease by Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip

“…NAFLD is an increasingly described disease in patients with inflammatory bowel disease (IBD). Recent data also indicate a frequent coexistence of metabolic syndrome in this group of patients. …”
Get full text

Immune-Mediated Cytotoxicity in Inflammatory Bowel Disease by Stephan R Targan, Richard L Deem, Fergus Shanahan

“…Thirty years of research on the role of immune-mediated cytotoxic activity in the tissue injury of inflammatory bowel disease (IBD) has yielded only inconclusive data on the relevance of cytotoxic mechanisms. …”
Get full text